Expansion opportunities Atomo Diagnostics is actively expanding internationally with recent commercial launches in New Zealand and ongoing plans to scale through a $4M fundraising to broaden Pascal cassette supply, indicating strong potential for channel partnerships, distributors, and regional sales acceleration.

Strategic partnerships Recent collaboration with BBI Solutions to combine technology and IP suggests a favorable environment for co-development deals, white-labeling opportunities, and joint ventures to broaden diagnostic offerings and accelerate market adoption.

Government funding Multiple government-backed grants and co-investment programs, including a $2.44M CRC Projects grant for rapid syphilis testing and government-supported StrepSure trials, create avenues for funded pilot programs and hospital or public-health procurement deals.

High-growth diagnostics Growing HIV self-test demand in Australia and planned scale-up of cassette supply point to sizable recurring needs for manufacturing capacity, distribution networks, and supply-chain services, enabling partnerships around logistics, fulfillment, and regulatory-compliant manufacturing.

Clinical validation Active collaborations with research and health institutions (Burnet Institute, Northern Health, RMIT) for rapid tests and sensor technologies indicate opportunities for sponsored trials, data-sharing partnerships, and evidence-based sales propositions to healthcare providers and payers.